Diskussionsleitung: H. U. Kreider-Stempfle (Bad Tölz), P. Lugenbiel (Heidelberg)
| (P1349) | Exenatid treatment improves cardiac diastolic dysfunction in diet induced obesity and increases GLUT4 expression and mitochondrial respiration | |
| K. Shahjerdi, L. Baensch, J. Weber, S. Saffak, A. Celik, J. Kielb, S. Glugla, H. Hu, M. Benkhoff, A. Lang, A. Polzin, T. Zeus, M. Kelm, B. Levkau, S. Weske, L. K. Dannenberg (Düsseldorf) | ||
| (P1350) | HFpEF is characterized by the expansion of Trem2 expressing macrophages in the myocardium | |
| N. Jurik, J. Leberzammer, S. Cremer, S. Dimmeler, B. Kattih, W. Abplanalp, D. John, M.-T. Katschke, für die Studiengruppe: DZHK (Frankfurt am Main) | ||
| (P1351) | Pressure-Volume Loop Analysis-based Assessment of Ventricular Interaction during Handgrip Exercise in Heart Failure with Preserved Ejection Fraction | |
| S. Rosch, K.-P. Rommel, K.-P. Kresoja, C. Besler, A. Schöber, T. Kister, M. von Roeder, C. Lücke, M. Gutberlet, H. Thiele, P. Lurz (Leipzig) | ||
| (P1352) | Inhibition of Class IIa HDACs reverses diastolic dysfunction in a murine HFpEF model. | |
| H. Paluvai, J. Huang, S. Nazir, J. Backs (Heidelberg) | ||
| (P1353) | Aldosterone induces HFpEF, atrial remodelling, and arrhythmia in mice | |
| D. Meral, A. Mamazhakypov, R. Emig, M. Calderón-Fernández, R. Peyronnet, C. Zgierski-Johnston, P. Kohl, L. Hein, S. Preissl, A. Lother (Freiburg, Freiburg im Breisgau) | ||
| (P1354) | Microsphere embolisation in hypertrophic obstructive cardiomyopathy: A quindecennial single-center experience | |
| E. Alyaydin, A. M. Jakstaite, R. A. Janosi, P. Lüdike, F. Al-Rashid, T. Rassaf, M. Papathanasiou (Essen) |